Ligand profile
ZINC4511491
Virtual-screening candidate from ZINC.
Bound to: KP13_03128 — Beta-lactamase CTX-M-2
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC4511491- UniProt (similar protein)
Q9L5C7- Tanimoto
- 1.000
- Target protein
- KP13_03128
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 89.3
- −1 ≤ LogP ≤ 5 0.90
- MW ≤ 500 Da 288.3
- LogP ≤ 5 0.90
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 89.3
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
O=c1c2c3c(sc2ncn1Cc1nnn[nH]1)CCCC3O=c1c2c3c(sc2ncn1Cc1nnn[nH]1)CCCC3
InChI=1S/C12H12N6OS/c19-12-10-7-3-1-2-4-8(7)20-11(10)13-6-18(12)5-9-14-16-17-15-9/h6H,1-5H2,(H,14,15,16,17)InChI=1S/C12H12N6OS/c19-12-10-7-3-1-2-4-8(7)20-11(10)13-6-18(12)5-9-14-16-17-15-9/h6H,1-5H2,(H,14,15,16,17)
QSBQXAOOVSQABJ-UHFFFAOYSA-NQSBQXAOOVSQABJ-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- 1CE
- Homolog
- Q9L5C7
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC4511491 →
- ZINC ZINC20 ZINC4511491 →
- UniProt UniProt Q9L5C7 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC4511491”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03128.
PDB 52
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 6
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).